TY - JOUR KW - Clofazimine KW - Dapsone KW - Half-Life KW - Humans KW - Kinetics KW - leprosy KW - Rifampin AU - Venkatesan K AU - Mathur A AU - Girdhar B K AU - Bharadwaj V P AB -

Fifteen untreated leprosy patients were given rifampicin and dapsone for seven days, and then rifampicin, dapsone and clofazimine for seven days. Concentrations of rifampicin and dapsone were estimated in timed plasma specimens and in 24 h urine specimens on days 7 and 14. No significant differences in the pharmacokinetics of rifampicin and dapsone were observed between the two occasions of sampling.

BT - The Journal of antimicrobial chemotherapy C1 - http://www.ncbi.nlm.nih.gov/pubmed/3818497?dopt=Abstract DA - 1986 Dec DO - 10.1093/jac/18.6.715 IS - 6 J2 - J. Antimicrob. Chemother. LA - eng N2 -

Fifteen untreated leprosy patients were given rifampicin and dapsone for seven days, and then rifampicin, dapsone and clofazimine for seven days. Concentrations of rifampicin and dapsone were estimated in timed plasma specimens and in 24 h urine specimens on days 7 and 14. No significant differences in the pharmacokinetics of rifampicin and dapsone were observed between the two occasions of sampling.

PY - 1986 SP - 715 EP - 8 T2 - The Journal of antimicrobial chemotherapy TI - The effect of clofazimine on the pharmacokinetics of rifampicin and dapsone in leprosy. VL - 18 SN - 0305-7453 ER -